See also this year's filing and all EDGAR filings for this company.
PDF Report 0001135906_2016_Epirus_Biopharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Keryx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001135906, Epirus Biopharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 35,247,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 32,771,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,073,000 |
| 3 | remainder_Assets | 2,173,000 |
| 4 | LiabilitiesCurrent | 33,281,000 |
| 5 | LiabilitiesNoncurrent | 425,000 |
| 6 | remainder_Liabilities | 2,190,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,080,624 |
| 9 | ResearchAndDevelopmentExpense | 31,322,744 |
| 10 | remainder_Expenses | -358,438 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -2,567,012 |
| 13 | remainder_ComprehensiveNetIncome | 399,911,965 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 72,264,000 |
| 1 | Liabilities | 35,896,000 |
| 2 | Expenses | 53,044,930 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 36,368,000 |
| 5 | NetIncome | -55,611,942 |
| 6 | ComprehensiveNetIncome | 144,344,040 |
| 7 | BaseVar | 281,841,954 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.14 |
| 9 | EconomicCapitalRatio | 4.49 |
Edgar->Model Mapping
Feature Distribution
Change over Time
